VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $784,732 | +26.4% | 101,781 | 0.0% | 0.02% | +31.2% |
| Q4 2022 | $620,864 | +3.0% | 101,781 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $603,000 | +17.5% | 101,781 | +17.3% | 0.02% | +33.3% |
| Q2 2022 | $513,000 | -22.4% | 86,781 | 0.0% | 0.01% | -7.7% |
| Q1 2022 | $661,000 | +561.0% | 86,781 | +135.9% | 0.01% | +550.0% |
| Q4 2021 | $100,000 | -79.1% | 36,781 | -79.8% | 0.00% | -77.8% |
| Q3 2021 | $478,000 | -26.0% | 181,881 | +16.4% | 0.01% | -25.0% |
| Q2 2021 | $646,000 | -48.1% | 156,300 | -40.9% | 0.01% | -47.8% |
| Q1 2021 | $1,245,000 | +88.1% | 264,339 | +655.3% | 0.02% | +283.3% |
| Q3 2018 | $662,000 | -51.6% | 35,000 | -50.0% | 0.01% | -57.1% |
| Q2 2018 | $1,368,000 | +4.0% | 70,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,315,000 | +13.2% | 70,000 | 0.0% | 0.01% | +7.7% |
| Q4 2017 | $1,162,000 | -19.4% | 70,000 | 0.0% | 0.01% | -18.8% |
| Q3 2017 | $1,441,000 | – | 70,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |